Therapeutic options against BCR-ABL1 T315I-positive chronic myelogenous leukemia.
Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia: a review.
"Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report.
Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T, Medeiros LJ, Hu S.
Curr Hematol Malig Rep. 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6.
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring.
Jabbour E, Kantarjian H.
Am J Hematol. 2024 Nov;99(11):2191-2212. doi: 10.1002/ajh.27443. Epub 2024 Aug 2.
Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring.
Jabbour E, Kantarjian H.
Am J Hematol. 2022 Sep;97(9):1236-1256. doi: 10.1002/ajh.26642. Epub 2022 Jul 6.
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
Osman AEG, Deininger MW.
Blood Rev. 2021 Sep;49:100825. doi: 10.1016/j.blre.2021.100825. Epub 2021 Mar 16.
Response and Resistance to BCR-ABL1-Targeted Therapies.
Braun TP, Eide CA, Druker BJ.
Cancer Cell. 2020 Apr 13;37(4):530-542. doi: 10.1016/j.ccell.2020.03.006.
Chronic Myeloid Leukemia: A Review.
Jabbour E, Kantarjian H.
JAMA. 2025 May 13;333(18):1618-1629. doi: 10.1001/jama.2025.0220.
Chronic Myeloid Leukemia in Children and Adolescents.
Gotesman M, Raheel S, Panosyan EH.
Adv Pediatr. 2023 Aug;70(1):145-155. doi: 10.1016/j.yapd.2023.04.002. Epub 2023 May 12.
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase.
Manley PW, Barys L, Cowan-Jacob SW.
Leuk Res. 2020 Nov;98:106458. doi: 10.1016/j.leukres.2020.106458. Epub 2020 Sep 29.
Suspected chronic myeloid leukemia-like BCR-ABL1-positive acute lymphoblastic leukemia.
Keino D, Kinoshita A, Sudo A, Ohyama R, Mori T.
Pediatr Int. 2021 Jun;63(6):728-729. doi: 10.1111/ped.14474. Epub 2021 May 26.
Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.
Jabbour E, Kantarjian H.
Am J Hematol. 2018 Mar;93(3):442-459. doi: 10.1002/ajh.25011.
